After an angiography, a collagen or suture piece is utilised as a vascular closure device. Vascular closure devices are useful in angiogram leaves an artery puncture. The punctured arteries are sealed using vascular closure devices. The patients' bodies are not negatively affected by the vascular closure devices.
The global Active Approximators Vascular Closure Device market was valued at US$ 867 million in 2023 and is anticipated to reach US$ 1438.4 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Cardiovascular disease (CVD) is one of the leading causes of death worldwide. The American Heart Association (AHA) estimated 18.6 million deaths from CVD in 2019. According to the American Heart Association, by 2030, 40.5% of the U.S. population will suffer from cardiovascular disease. Therefore, as the prevalence of cardiovascular diseases rises, the demand for catheterization and interventional procedures for the diagnosis and treatment of cardiovascular diseases is expected to increase. The market for active accessor vessel closure devices is expected to witness significant growth over the next few years owing to the increasing popularity of these treatments.
This report aims to provide a comprehensive presentation of the global market for Active Approximators Vascular Closure Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Active Approximators Vascular Closure Device.
Report Scope
The Active Approximators Vascular Closure Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Active Approximators Vascular Closure Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Active Approximators Vascular Closure Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Terumo Corporation
Abbott
Cardinal Health
Cardiva Medical, Inc
Medtronic
Morris Innovative
Teleflex Incorporated
Merit Medical Systems
Vasorum Ltd
TZ Medical
Vivasure Medical Ltd
Tricol Biomedical
Scion Biomedical
Advanced Vascular Dynamics
Marine Polymer Technologies, Inc
Transluminal Technologies
Segment by Type
Passive Approximator
Active Approximator
Segment by Application
Diagnostic Intervention
Therapeutic Interventions
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Active Approximators Vascular Closure Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Active Approximators Vascular Closure Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Active Approximators Vascular Closure Device Market Overview
1.1 Product Overview and Scope of Active Approximators Vascular Closure Device
1.2 Active Approximators Vascular Closure Device Segment by Type
1.2.1 Global Active Approximators Vascular Closure Device Market Value Comparison by Type (2024-2030)
1.2.2 Passive Approximator
1.2.3 Active Approximator
1.3 Active Approximators Vascular Closure Device Segment by Application
1.3.1 Global Active Approximators Vascular Closure Device Market Value by Application: (2024-2030)
1.3.2 Diagnostic Intervention
1.3.3 Therapeutic Interventions
1.3.4 Other
1.4 Global Active Approximators Vascular Closure Device Market Size Estimates and Forecasts
1.4.1 Global Active Approximators Vascular Closure Device Revenue 2019-2030
1.4.2 Global Active Approximators Vascular Closure Device Sales 2019-2030
1.4.3 Global Active Approximators Vascular Closure Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Active Approximators Vascular Closure Device Market Competition by Manufacturers
2.1 Global Active Approximators Vascular Closure Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Active Approximators Vascular Closure Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Active Approximators Vascular Closure Device Average Price by Manufacturers (2019-2024)
2.4 Global Active Approximators Vascular Closure Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Active Approximators Vascular Closure Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Active Approximators Vascular Closure Device, Product Type & Application
2.7 Active Approximators Vascular Closure Device Market Competitive Situation and Trends
2.7.1 Active Approximators Vascular Closure Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Active Approximators Vascular Closure Device Players Market Share by Revenue
2.7.3 Global Active Approximators Vascular Closure Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Active Approximators Vascular Closure Device Retrospective Market Scenario by Region
3.1 Global Active Approximators Vascular Closure Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Active Approximators Vascular Closure Device Global Active Approximators Vascular Closure Device Sales by Region: 2019-2030
3.2.1 Global Active Approximators Vascular Closure Device Sales by Region: 2019-2024
3.2.2 Global Active Approximators Vascular Closure Device Sales by Region: 2025-2030
3.3 Global Active Approximators Vascular Closure Device Global Active Approximators Vascular Closure Device Revenue by Region: 2019-2030
3.3.1 Global Active Approximators Vascular Closure Device Revenue by Region: 2019-2024
3.3.2 Global Active Approximators Vascular Closure Device Revenue by Region: 2025-2030
3.4 North America Active Approximators Vascular Closure Device Market Facts & Figures by Country
3.4.1 North America Active Approximators Vascular Closure Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Active Approximators Vascular Closure Device Sales by Country (2019-2030)
3.4.3 North America Active Approximators Vascular Closure Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Active Approximators Vascular Closure Device Market Facts & Figures by Country
3.5.1 Europe Active Approximators Vascular Closure Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Active Approximators Vascular Closure Device Sales by Country (2019-2030)
3.5.3 Europe Active Approximators Vascular Closure Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Active Approximators Vascular Closure Device Market Facts & Figures by Country
3.6.1 Asia Pacific Active Approximators Vascular Closure Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Active Approximators Vascular Closure Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Active Approximators Vascular Closure Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Active Approximators Vascular Closure Device Market Facts & Figures by Country
3.7.1 Latin America Active Approximators Vascular Closure Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Active Approximators Vascular Closure Device Sales by Country (2019-2030)
3.7.3 Latin America Active Approximators Vascular Closure Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Active Approximators Vascular Closure Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Active Approximators Vascular Closure Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Active Approximators Vascular Closure Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Active Approximators Vascular Closure Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Active Approximators Vascular Closure Device Sales by Type (2019-2030)
4.1.1 Global Active Approximators Vascular Closure Device Sales by Type (2019-2024)
4.1.2 Global Active Approximators Vascular Closure Device Sales by Type (2025-2030)
4.1.3 Global Active Approximators Vascular Closure Device Sales Market Share by Type (2019-2030)
4.2 Global Active Approximators Vascular Closure Device Revenue by Type (2019-2030)
4.2.1 Global Active Approximators Vascular Closure Device Revenue by Type (2019-2024)
4.2.2 Global Active Approximators Vascular Closure Device Revenue by Type (2025-2030)
4.2.3 Global Active Approximators Vascular Closure Device Revenue Market Share by Type (2019-2030)
4.3 Global Active Approximators Vascular Closure Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Active Approximators Vascular Closure Device Sales by Application (2019-2030)
5.1.1 Global Active Approximators Vascular Closure Device Sales by Application (2019-2024)
5.1.2 Global Active Approximators Vascular Closure Device Sales by Application (2025-2030)
5.1.3 Global Active Approximators Vascular Closure Device Sales Market Share by Application (2019-2030)
5.2 Global Active Approximators Vascular Closure Device Revenue by Application (2019-2030)
5.2.1 Global Active Approximators Vascular Closure Device Revenue by Application (2019-2024)
5.2.2 Global Active Approximators Vascular Closure Device Revenue by Application (2025-2030)
5.2.3 Global Active Approximators Vascular Closure Device Revenue Market Share by Application (2019-2030)
5.3 Global Active Approximators Vascular Closure Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Terumo Corporation
6.1.1 Terumo Corporation Corporation Information
6.1.2 Terumo Corporation Description and Business Overview
6.1.3 Terumo Corporation Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Terumo Corporation Active Approximators Vascular Closure Device Product Portfolio
6.1.5 Terumo Corporation Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Active Approximators Vascular Closure Device Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Cardinal Health
6.3.1 Cardinal Health Corporation Information
6.3.2 Cardinal Health Description and Business Overview
6.3.3 Cardinal Health Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cardinal Health Active Approximators Vascular Closure Device Product Portfolio
6.3.5 Cardinal Health Recent Developments/Updates
6.4 Cardiva Medical, Inc
6.4.1 Cardiva Medical, Inc Corporation Information
6.4.2 Cardiva Medical, Inc Description and Business Overview
6.4.3 Cardiva Medical, Inc Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardiva Medical, Inc Active Approximators Vascular Closure Device Product Portfolio
6.4.5 Cardiva Medical, Inc Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medtronic Active Approximators Vascular Closure Device Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Morris Innovative
6.6.1 Morris Innovative Corporation Information
6.6.2 Morris Innovative Description and Business Overview
6.6.3 Morris Innovative Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Morris Innovative Active Approximators Vascular Closure Device Product Portfolio
6.6.5 Morris Innovative Recent Developments/Updates
6.7 Teleflex Incorporated
6.6.1 Teleflex Incorporated Corporation Information
6.6.2 Teleflex Incorporated Description and Business Overview
6.6.3 Teleflex Incorporated Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teleflex Incorporated Active Approximators Vascular Closure Device Product Portfolio
6.7.5 Teleflex Incorporated Recent Developments/Updates
6.8 Merit Medical Systems
6.8.1 Merit Medical Systems Corporation Information
6.8.2 Merit Medical Systems Description and Business Overview
6.8.3 Merit Medical Systems Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merit Medical Systems Active Approximators Vascular Closure Device Product Portfolio
6.8.5 Merit Medical Systems Recent Developments/Updates
6.9 Vasorum Ltd
6.9.1 Vasorum Ltd Corporation Information
6.9.2 Vasorum Ltd Description and Business Overview
6.9.3 Vasorum Ltd Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vasorum Ltd Active Approximators Vascular Closure Device Product Portfolio
6.9.5 Vasorum Ltd Recent Developments/Updates
6.10 TZ Medical
6.10.1 TZ Medical Corporation Information
6.10.2 TZ Medical Description and Business Overview
6.10.3 TZ Medical Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 TZ Medical Active Approximators Vascular Closure Device Product Portfolio
6.10.5 TZ Medical Recent Developments/Updates
6.11 Vivasure Medical Ltd
6.11.1 Vivasure Medical Ltd Corporation Information
6.11.2 Vivasure Medical Ltd Active Approximators Vascular Closure Device Description and Business Overview
6.11.3 Vivasure Medical Ltd Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vivasure Medical Ltd Active Approximators Vascular Closure Device Product Portfolio
6.11.5 Vivasure Medical Ltd Recent Developments/Updates
6.12 Tricol Biomedical
6.12.1 Tricol Biomedical Corporation Information
6.12.2 Tricol Biomedical Active Approximators Vascular Closure Device Description and Business Overview
6.12.3 Tricol Biomedical Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tricol Biomedical Active Approximators Vascular Closure Device Product Portfolio
6.12.5 Tricol Biomedical Recent Developments/Updates
6.13 Scion Biomedical
6.13.1 Scion Biomedical Corporation Information
6.13.2 Scion Biomedical Active Approximators Vascular Closure Device Description and Business Overview
6.13.3 Scion Biomedical Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Scion Biomedical Active Approximators Vascular Closure Device Product Portfolio
6.13.5 Scion Biomedical Recent Developments/Updates
6.14 Advanced Vascular Dynamics
6.14.1 Advanced Vascular Dynamics Corporation Information
6.14.2 Advanced Vascular Dynamics Active Approximators Vascular Closure Device Description and Business Overview
6.14.3 Advanced Vascular Dynamics Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Advanced Vascular Dynamics Active Approximators Vascular Closure Device Product Portfolio
6.14.5 Advanced Vascular Dynamics Recent Developments/Updates
6.15 Marine Polymer Technologies, Inc
6.15.1 Marine Polymer Technologies, Inc Corporation Information
6.15.2 Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Description and Business Overview
6.15.3 Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Marine Polymer Technologies, Inc Active Approximators Vascular Closure Device Product Portfolio
6.15.5 Marine Polymer Technologies, Inc Recent Developments/Updates
6.16 Transluminal Technologies
6.16.1 Transluminal Technologies Corporation Information
6.16.2 Transluminal Technologies Active Approximators Vascular Closure Device Description and Business Overview
6.16.3 Transluminal Technologies Active Approximators Vascular Closure Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Transluminal Technologies Active Approximators Vascular Closure Device Product Portfolio
6.16.5 Transluminal Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Active Approximators Vascular Closure Device Industry Chain Analysis
7.2 Active Approximators Vascular Closure Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Active Approximators Vascular Closure Device Production Mode & Process
7.4 Active Approximators Vascular Closure Device Sales and Marketing
7.4.1 Active Approximators Vascular Closure Device Sales Channels
7.4.2 Active Approximators Vascular Closure Device Distributors
7.5 Active Approximators Vascular Closure Device Customers
8 Active Approximators Vascular Closure Device Market Dynamics
8.1 Active Approximators Vascular Closure Device Industry Trends
8.2 Active Approximators Vascular Closure Device Market Drivers
8.3 Active Approximators Vascular Closure Device Market Challenges
8.4 Active Approximators Vascular Closure Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Terumo Corporation
Abbott
Cardinal Health
Cardiva Medical, Inc
Medtronic
Morris Innovative
Teleflex Incorporated
Merit Medical Systems
Vasorum Ltd
TZ Medical
Vivasure Medical Ltd
Tricol Biomedical
Scion Biomedical
Advanced Vascular Dynamics
Marine Polymer Technologies, Inc
Transluminal Technologies
听
听
*If Applicable.
